Wells Fargo & Company Seres Therapeutics, Inc. Transaction History

Wells Fargo & Company

  • $429 Billion
  • Q1 2025

A detailed history of Wells Fargo & Company transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 7,800 shares of MCRB stock, worth $71,994. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,800
Previous 200 3800.0%
Holding current value
$71,994
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$0.64 - $0.91 $4,864 - $6,916
7,600 Added 3800.0%
7,800 $5,000
Q2 2024

Aug 13, 2024
SELL
$0.56 - $1.19 $17,468 - $37,120
-31,194 Reduced 99.36%
200 $0
Q1 2024

May 10, 2024
BUY
$0.75 - $1.56 $2,551 - $5,307
3,402 Added 12.15%
31,394 $24,000
Q4 2023

Feb 09, 2024
SELL
$0.93 - $2.15 $153,721 - $355,377
-165,292 Reduced 85.52%
27,992 $39,000
Q3 2023

Nov 13, 2023
BUY
$2.33 - $5.07 $50,039 - $108,883
21,476 Added 12.5%
193,284 $460,000
Q2 2023

Aug 15, 2023
BUY
$4.67 - $6.55 $545,852 - $765,596
116,885 Added 212.82%
171,808 $822,000
Q1 2023

May 12, 2023
BUY
$4.95 - $6.09 $265,621 - $326,795
53,661 Added 4252.06%
54,923 $311,000
Q4 2022

Feb 13, 2023
SELL
$5.09 - $9.05 $14,822 - $26,353
-2,912 Reduced 69.77%
1,262 $7,000
Q3 2022

Nov 14, 2022
BUY
$3.5 - $7.2 $3,143 - $6,465
898 Added 27.41%
4,174 $26,000
Q2 2022

Aug 12, 2022
SELL
$2.7 - $7.62 $17,334 - $48,920
-6,420 Reduced 66.21%
3,276 $12,000
Q1 2022

May 16, 2022
SELL
$6.3 - $8.84 $147,048 - $206,334
-23,341 Reduced 70.65%
9,696 $70,000
Q4 2021

Feb 14, 2022
SELL
$6.02 - $11.43 $133,174 - $252,854
-22,122 Reduced 40.11%
33,037 $275,000
Q3 2021

Nov 15, 2021
BUY
$5.46 - $22.6 $142,495 - $589,814
26,098 Added 89.8%
55,159 $384,000
Q2 2021

Aug 16, 2021
SELL
$18.46 - $24.36 $584,757 - $771,651
-31,677 Reduced 52.15%
29,061 $693,000
Q1 2021

May 13, 2021
SELL
$17.66 - $28.92 $1.02 Million - $1.67 Million
-57,830 Reduced 48.77%
60,738 $1.25 Million
Q4 2020

Feb 09, 2021
SELL
$23.25 - $37.73 $395,482 - $641,787
-17,010 Reduced 12.55%
118,568 $2.91 Million
Q3 2020

Nov 05, 2020
BUY
$3.74 - $28.74 $146,982 - $1.13 Million
39,300 Added 40.82%
135,578 $3.84 Million
Q2 2020

Aug 13, 2020
BUY
$3.04 - $6.2 $43,903 - $89,540
14,442 Added 17.65%
96,278 $459,000
Q1 2020

May 14, 2020
BUY
$2.64 - $3.82 $216,047 - $312,613
81,836 New
81,836 $292,000

Others Institutions Holding MCRB

# of Institutions
65
Shares Held
39.4M
Call Options Held
103K
Put Options Held
53K
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $1.15B
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email